U.S. market Closed. Opens in 16 hours 53 minutes

COYA | Coya Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
Revenue6.00MN/AN/AN/A
Cost of Revenue27.36K27.36K16.13KN/A
Gross Profit5.97M-27.36K-16.13KN/A
Operating Expenses13.34M9.81M4.87M694.77K
Selling, General & Admin7.83M4.85M2.31M445.80K
Research & Development5.50M4.94M2.54M248.97K
Other Operating Expenses639.37K27.36K16.13KN/A
Operating Income-7.36M-9.81M-4.87M-694.77K
Other Expenses / Income96.18K-2.43M-21.48K-38.42K
Before Tax Income-7.26M-12.24M-4.89M-733.20K
Income Tax Expenses723.85K2.43M-21.48K-704.00
Net Income-7.99M-14.68M-4.87M-733.20K
Interest ExpensesN/A2.43MN/A38.98K
Basic Shares Outstanding10.16M9.95M9.68M9.68M
Diluted Shares Outstanding10.16M9.95M9.68M9.68M
EBITDA-7.33M-9.78M-4.88M-694.77K
EBITDA Margin-122.17%0.00%0.00%0.00%
EBIT-7.26M-9.81M-4.89M-694.92K
EBIT Margin-121.02%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙